SAN DIEGO, January 31, 2012 – Profil® Institute for Clinical Research, Inc., a company focused on early phase clinical trials for diabetes and obesity, announced today the appointment of Dr. John Amatruda, a pharmaceutical research executive, and Dr. Jerrold Olefsky, professor of medicine at the University of California, San Diego, to its Board of Directors.

Profil Institute the Only Clinical Research Institute Exhibiting at Annual Meeting, Strengthening Company’s Position as a Leading Specialized Provider of Phase I Clinical Trials in Diabetes

SAN DIEGO, September 12, 2011 – Profil® Institute for Clinical Research, Inc., a specialized contract research institute optimizing early phase diabetes, obesity and cardiometabolic drug development, will present key clinical and experimental diabetes and insulin-related research at the European Association for the Study of Diabetes (EASD) 47th Annual Meeting being held September 12 - 16 in Lisbon, Portugal.

SAN DIEGO, June 16, 2011 – Profil® Institute for Clinical Research, Inc., a company leading the industry in early phase clinical trials for diabetes and obesity, announced today the appointment of Dr. Andrew Krentz as Senior Director of Scientific Services. Dr. Krentz, who is currently a senior scientific consultant for Profil Institute, will take on his new position in October following his relocation from the UK to San Diego. In his new role he will oversee Profil Institute’s scientific services department and its integrated, science-driven approach from clinical trial protocol design to the publication of metabolic studies.

SAN DIEGO and SAN CARLOS, CA, June 8, 2011 – Profil™ Institute for Clinical Research, Inc., a company leading the industry in early phase clinical trials for diabetes and obesity, and Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, jointly announced today a strategic alliance to offer Profil Institute customers use of Rosa’s modeling technology to simulate disease physiology, drug action, patient variability, and trial outcomes for their early phase clinical development programs.

SAN DIEGO, April  20, 2011 – Profil™ Institute for Clinical Research, Inc., a company leading the industry in early phase clinical trials for diabetes and obesity, announced today its sponsorship of the American Diabetes Association’s Tour de Cure, an annual nationally recognized cycling event on Saturday, May 7 in Cardiff By The Sea.

SAN DIEGO, April 07, 2011 /PRNewswire/ – Profil™ Institute for Clinical Research, Inc., a company leading the industry in early phase clinical trials for diabetes and obesity, announced today that the American Diabetes Association’s CEO Larry Hausner visited Profil Institute’s office to acknowledge the contributions that the company has made to support the Association at a national and local level.

SAN DIEGO, January  27, 2011 /PRNewswire/ – Profil™ Institute for Clinical Research, Inc., a company leading the industry in early phase clinical trials for diabetes and obesity, announced today that CEO Dr. Marcus Hompesch is an invited speaker at the Ramanbhai Foundation 5th International Symposium and ISCR’s 4th Annual Clinical Research Conference in February. 

SAN DIEGO, November 22, 2010 /PRNewswire/ – Profil™ Institute for Clinical Research, Inc., a company specializing in early phase clinical trials for diabetes and obesity, announced today the expansion of its capabilities for cardiac safety and cardiovascular efficacy studies in the company’s early phase diabetes and obesity clinical trials.

SAN DIEGO, October 7, 2010 /PRNewswire/ – Profil™ Institute for Clinical Research, Inc., a company specializing in early phase clinical trials for diabetes and obesity, announced today the initiation of patient screening in Orange County for clinical trial eligibility at the company’s San Diego clinical facility.  

SAN DIEGO, September 15, 2010 – Profil™ Institute for Clinical Research, Inc. will present key clinical and experimental diabetes and insulin-related research at the European Association of the Study of Diabetes (EASD) 46th Annual Meeting being held September 20 – 24 in Stockholm, Sweden.  Profil Institute’s presence as a contributor of scientific presentations emphasizes the company’s position as a specialized contract research institute optimizing early phase diabetes, obesity and cardiometabolic drug development.

SAN DIEGO, July 8, 2010 /PRNewswire/ – Profil™ Institute for Clinical Research, Inc., a company specializing in early phase clinical trials for diabetes and obesity, announced today that Dr. Marcus Hompesch, the company’s President and CEO, will serve as San Diego’s 2010 Corporate Chairman for Step Out: Walk to Fight Diabetes, the American Diabetes Association’s (ADA) largest fund-raising event.

SAN DIEGO, June 22, 2010 – Profil™ Institute for Clinical Research, Inc. will present the company’s key clinical and experimental diabetes and insulin-related research at the American Diabetes Association 70th Scientific Sessions 2010 Annual Meeting being held June 25 – 29 in Orlando, Fla.  Profil’s presence as a contributor of scientific presentations emphasizes and confirms the unique role the institute plays as a specialized contract research institute in the early phase diabetes drug development process.

SAN DIEGO, June 17, 2010 /PRNewswire/ – Profil™ Institute for Clinical Research, Inc., a company specializing in early phase clinical trials for diabetes and obesity, announced today the appointment of Prof. Dr. Lutz Heinemann as Director of Scientific Services and Robert J. Schott, MD, MPH, FACC as Director of Cardiometabolic Research. Prof. Dr. Heinemann will oversee the scientific aspects of Profil's integrated approach from clinical trial protocol design to the publication of study results. Dr. Schott will oversee the design and execution of cardiometabolic and cardiac safety studies for the company’s biopharmaceutical clients.

"We couldn’t be more pleased to have Drs. Heinemann and Schott join the Profil scientific management team where they will have a direct impact on finding better treatments for diabetes and obesity," said Dr. Marcus Hompesch, Profil President and CEO.

SAN DIEGO, June 14, 2010 – Profil™ Institute for Clinical Research, Inc. (PICR) today announced that Director of Human Resources Susan Penn is a finalist for San Diego’s 3rd Annual HR Professional of the Year Awards hosted by San Diego Business Journal. Award winners will be announced at a gala event on June 17, 2010 at the Hilton San Diego Bayfront Hotel.
 

SAN DIEGO, May 12, 2010 /PRNewswire/ – Profil™ Institute for Clinical Research, Inc. (PICR) today announced that president and CEO
Dr. Marcus Hompesch is a finalist for the Ernst & Young Entrepreneur Of The Year® 2010 Award in San Diego for the second year in a row. Award winners will be announced at a gala event on June 9, 2010 at the Hyatt La Jolla Aventine.